Safety and efficacy of osimertinib plus consolidative stereotactic ablative radiation (SABR) in advanced EGFR mutant non-small cell lung cancer (NSCLC): Results from a multi-center phase II trial Meeting Abstract
| Authors: | Rashdan, S.; Sampath, S.; Iyengar, P.; Dowell, J.; Ahn, C.; Westover, K. D.; Zhang, Y.; Cole, S.; Massarelli, E.; Amini, A.; Koczywas, M.; Gerber, D. E. |
| Abstract Title: | Safety and efficacy of osimertinib plus consolidative stereotactic ablative radiation (SABR) in advanced EGFR mutant non-small cell lung cancer (NSCLC): Results from a multi-center phase II trial |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402016 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.8518 |
| Notes: | Meeting Abstract: 8518 -- Source: Wos |
